O-beta-D-fructofuranosyl-(2→6)-alpha-D-glucopyranosyl-(1→6)-beta-D-fructofuranosyl-(2→6)-beta-D-fructofuranosyl-(2→1)-alpha-D-glucopyranosyl-(6→2)-beta-D-fructofuranoside - Compound Card

O-beta-D-fructofuranosyl-(2→6)-alpha-D-glucopyranosyl-(1→6)-beta-D-fructofuranosyl-(2→6)-beta-D-fructofuranosyl-(2→1)-alpha-D-glucopyranosyl-(6→2)-beta-D-fructofuranoside

Select a section from the left sidebar

O-beta-D-fructofuranosyl-(2→6)-alpha-D-glucopyranosyl-(1→6)-beta-D-fructofuranosyl-(2→6)-beta-D-fructofuranosyl-(2→1)-alpha-D-glucopyranosyl-(6→2)-beta-D-fructofuranoside

Structure
Zoomed Structure
  • Family: Plantae - Zygophyllaceae
  • Kingdom: Plantae
  • Class: Oligosaccharide
Canonical Smiles OC[C@H]1O[C@]([C@H]([C@@H]1O)O)(O)COC[C@H]1O[C@H](OC[C@H]2O[C@@]([C@H]([C@@H]2O)O)(CO)OC[C@H]2O[C@@]([C@H]([C@@H]2O)O)(CO)O[C@@H]2O[C@@H](CO[C@@]3(CO)O[C@H]([C@@H]([C@H]3O)O)CO)[C@@H]([C@H]([C@@H]2O)O)O)[C@@H]([C@H]([C@@H]1O)O)O
InChI InChI=1S/C36H62O31/c37-1-11-19(44)27(52)33(56,63-11)10-57-3-13-17(42)23(48)25(50)31(61-13)58-4-15-21(46)29(54)35(8-40,65-15)60-6-16-22(47)30(55)36(9-41,66-16)67-32-26(51)24(49)18(43)14(62-32)5-59-34(7-39)28(53)20(45)12(2-38)64-34/h11-32,37-56H,1-10H2/t11-,12+,13-,14+,15-,16-,17-,18+,19-,20+,21-,22-,23+,24-,25-,26+,27+,28-,29+,30+,31+,32+,33-,34+,35-,36+/m1/s1
InChIKey JPWSDMVCZKGSOY-WPCGLFGJSA-N
Formula C36H62O31
HBA 31
HBD 20
MW 990.86
Rotatable Bonds 20
TPSA 506.13
LogP -14.09
Number Rings 6
Number Aromatic Rings 0
Heavy Atom Count 67
Formal Charge 0
Fraction CSP3 1.0
Exact Mass 990.33
Number of Lipinski Rule Violations 3
# Species Family Kingdom NCBI Taxonomy ID
1 Tribulus terrestris Zygophyllaceae Plantae 210369

Showing of synonyms

  • Hammoda HM, Ghazy NM, et al. (2013). Chemical constituents from Tribulus terrestris and screening of their antioxidant activity. Phytochemistry,2013,92,153-159. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: O1CCCC1COCC2CCCC(O2)OCC3CCC(O3)OCC4CCC(O4)OC(O5)CCCC5COC6CCCO6

Level: 5

Mol. Weight: 990.86 g/mol

Structure

SMILES: O1CCCC1COCC2CCCC(O2)OCC3CCC(O3)OCC4CCC(O4)OC5CCCCO5

Level: 4

Mol. Weight: 990.86 g/mol

Structure

SMILES: O1CCCCC1OCC2CCC(O2)OCC3CCC(O3)OC(O4)CCCC4COC5CCCO5

Level: 4

Mol. Weight: 990.86 g/mol

Structure

SMILES: O1CCCC1COCC2CCCC(O2)OCC3CCC(O3)OCC4CCCO4

Level: 3

Mol. Weight: 990.86 g/mol

Structure

SMILES: O1CCCCC1OC(O2)CCC2COC(O3)CCC3COC4CCCCO4

Level: 3

Mol. Weight: 990.86 g/mol

Structure

SMILES: O1CCCC1OCC2CCC(O2)OC(O3)CCCC3COC4CCCO4

Level: 3

Mol. Weight: 990.86 g/mol

Structure

SMILES: O1CCCC1COCC2CCCC(O2)OCC3CCCO3

Level: 2

Mol. Weight: 990.86 g/mol

Structure

SMILES: O1CCCC1COC(O2)CCC2COC3CCCCO3

Level: 2

Mol. Weight: 990.86 g/mol

Structure

SMILES: O1CCCC1OCC2CCCC(O2)OC3CCCO3

Level: 2

Mol. Weight: 990.86 g/mol

Structure

SMILES: O1CCCC1OCC2CCC(O2)OC3CCCCO3

Level: 2

Mol. Weight: 990.86 g/mol

Structure

SMILES: O1CCCC1COCC2CCCCO2

Level: 1

Mol. Weight: 990.86 g/mol

Structure

SMILES: O1CCCCC1COC2CCCO2

Level: 1

Mol. Weight: 990.86 g/mol

Structure

SMILES: O1CCCC1COC2CCCCO2

Level: 1

Mol. Weight: 990.86 g/mol

Structure

SMILES: O1CCCC1OC2CCCCO2

Level: 1

Mol. Weight: 990.86 g/mol

Structure

SMILES: O1CCCC1COC2CCCO2

Level: 1

Mol. Weight: 990.86 g/mol

Structure

SMILES: C1CCOCC1

Level: 0

Mol. Weight: 990.86 g/mol

Structure

SMILES: C1CCOC1

Level: 0

Mol. Weight: 990.86 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-6.67
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Non-Absorbed
Madin-Darby Canine Kidney
4903.930
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
641906.49

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.440
Plasma Protein Binding
29.43
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Non-Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
4.280
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Toxic
Bee
Safe
Bioconcentration Factor
-14914.420
Biodegradation
Toxic
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Toxic
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
1.710
Liver Injury II
Safe
hERG Blockers
Safe
Daphnia Maga
4.050
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Toxic
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-1165020712.710
Rat (Acute)
1.920
Rat (Chronic Oral)
4.400
Fathead Minnow
1470599.670
Respiratory Disease
Safe
Skin Sensitisation
Toxic
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
131026022.440
Hydration Free Energy
-2.920
Log(D) at pH=7.4
-64.530
Log(P)
-9.14
Log S
0.52
Log(Vapor Pressure)
-4314447.96
Melting Point
193.6
pKa Acid
-31346.98
pKa Basic
-226.53

No predicted protein targets found for this compound.

Download SDF